DETERMINANTS OF THE EFFECTS OF SGLT2I ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL

Back

Abstract Number

WCN23-0342

Categories

Late Breaking Clinical Trials

Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD

Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy

Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care

Topic - Special Covid-19

Topic - Education

Abstract Title

DETERMINANTS OF THE EFFECTS OF SGLT2I ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL

Co-authors

Staplin, N.(1)*;Haynes, R.(1);Herrington, W.(1);Empa-Kidney Collaborative Group, O.B.O.(1);

ie:	Azwin Z.1, Siti Y.1, John D.2

Institution

(1)University Of Oxford, Nuffield Department Of Population Health, Oxford, United Kingdom;

E-Poster

https://storage.unitedwebnetwork.com/files/1041/52df661bb48962c1d8f321afffd404bd.pptx

Audio File

if any